CN Stock MarketDetailed Quotes

301096 Hangzhou Bio-Sincerity Pharma-Tech

Watchlist
  • 32.83
  • +0.36+1.11%
Trading Apr 25 13:54 CST
3.59BMarket Cap-27.85P/E (TTM)

Hangzhou Bio-Sincerity Pharma-Tech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
Total operating revenue
-40.32%128.73M
-21.18%801.92M
1.07%721.48M
23.88%525.06M
34.04%215.7M
67.51%1.02B
69.65%713.81M
72.53%423.86M
67.97%160.92M
62.27%607.41M
Operating revenue
-40.32%128.73M
-21.18%801.92M
1.07%721.48M
23.88%525.06M
34.04%215.7M
67.51%1.02B
69.65%713.81M
72.53%423.86M
67.97%160.92M
62.27%607.41M
Other operating revenue
----
594.36%771.48K
----
--0
----
--111.11K
----
--0
----
--0
Total operating cost
0.13%164.77M
13.35%809.89M
21.10%580.69M
33.98%384.88M
30.67%164.55M
64.56%714.53M
75.21%479.52M
72.65%287.27M
56.00%125.93M
67.17%434.2M
Operating cost
9.54%75.16M
9.79%385.06M
20.09%280.15M
15.75%164.07M
24.29%68.61M
76.98%350.74M
83.36%233.29M
67.66%141.74M
74.43%55.2M
61.74%198.18M
Operating tax surcharges
-5.03%2.31M
73.52%9.9M
130.57%7.41M
312.20%5.03M
1,714.38%2.43M
128.88%5.7M
113.09%3.21M
128.00%1.22M
-126.58%-150.76K
332.87%2.49M
Operating expense
75.89%2.59M
55.01%14.96M
67.98%11.34M
59.94%6.88M
-34.67%1.47M
23.08%9.65M
32.86%6.75M
24.66%4.3M
39.06%2.25M
16.90%7.84M
Administration expense
-4.45%26.8M
-39.77%77.47M
-54.20%45.4M
0.77%61.73M
-6.95%28.05M
26.82%128.63M
66.97%99.13M
106.77%61.26M
116.60%30.14M
111.76%101.43M
Financial expense
368.22%3.44M
119.83%4.21M
107.92%1.33M
88.47%-1.51M
79.17%-1.28M
49.28%-21.21M
49.17%-16.83M
41.81%-13.06M
44.22%-6.16M
-4,845.03%-41.81M
-Interest expense (Financial expense)
25.49%4.31M
139.85%17.05M
173.75%12.11M
213.43%7.77M
2,063.42%3.43M
438.83%7.11M
348.79%4.42M
172.17%2.48M
-80.20%158.75K
-64.00%1.32M
-Interest Income (Financial expense)
80.60%-923.67K
54.22%-13.04M
49.08%-10.91M
40.39%-9.36M
25.53%-4.76M
32.20%-28.48M
34.82%-21.43M
30.22%-15.71M
43.18%-6.39M
-1,749.73%-42.01M
Research and development
-16.56%54.47M
32.06%318.29M
52.66%235.05M
61.94%148.68M
46.22%65.27M
45.13%241.02M
35.53%153.97M
29.89%91.81M
1.42%44.64M
104.68%166.07M
Credit Impairment Loss
17.78%-1.56M
-213.51%-30.91M
-284.65%-13.86M
-238.74%-10.36M
-8.54%-1.9M
-38.11%-9.86M
-7.14%-3.6M
-322.42%-3.06M
-49.88%-1.75M
-126.61%-7.14M
Asset Impairment Loss
93.55%-172.4K
21.82%-10.09M
17.64%-6.25M
-40.35%-8.76M
-72.74%-2.67M
-342.41%-12.91M
-179.00%-7.59M
-521.27%-6.24M
-228.85%-1.55M
-101.20%-2.92M
Other net revenue
342.97%8.12M
-348.15%-26.43M
-16.21%-9.95M
16.10%-6.24M
-27.56%-3.34M
-138.23%-5.9M
-325.38%-8.56M
-872.93%-7.44M
-247.44%-2.62M
250.07%15.43M
Fair value change income
----
----
----
----
----
----
----
----
----
---2.92M
Invest income
3,354.81%1.08M
-5,081.61%-5.59M
-6,331.89%-6.59M
23.10%130.09K
--31.27K
89.78%-107.91K
110.01%105.68K
113.81%105.68K
----
-62.29%-1.06M
-Including: Investment income associates
----
-7,008.51%-7.05M
---6.91M
--72.03K
--31.27K
113.33%102.05K
----
----
----
15.63%-765.36K
Asset deal income
--0
----
----
----
--0
5,050.07%780.71K
--958.06K
--968.78K
----
--15.16K
Other revenue
634.24%8.78M
24.49%20.16M
966.69%16.75M
1,524.17%12.75M
77.16%1.2M
-44.99%16.2M
-80.48%1.57M
-87.68%784.74K
-88.87%674.9K
204.83%29.44M
Operating profit
-158.39%-27.91M
-111.58%-34.39M
-42.04%130.83M
3.71%133.94M
47.67%47.81M
57.45%297.02M
55.62%225.72M
60.95%129.16M
92.02%32.37M
58.54%188.64M
Add:Non operating Income
62.01%151.55K
4.18%400.76K
-11.63%281.68K
-13.88%165.26K
306.92%93.54K
-84.16%384.7K
-96.68%318.74K
-98.00%191.9K
-36.04%22.99K
1,567.96%2.43M
Less:Non operating expense
1,385.72%22.41K
19.76%2.07M
-76.19%400.26K
-99.90%1.56K
-95.31%1.51K
941.31%1.73M
934.56%1.68M
1,149.98%1.64M
-70.54%32.18K
-11.53%165.84K
Total profit
-158.01%-27.78M
-112.20%-36.06M
-41.74%130.72M
5.01%134.11M
48.00%47.9M
54.88%295.68M
45.22%224.36M
42.39%127.71M
92.80%32.36M
60.50%190.91M
Less:Income tax cost
17.41%-1.59M
-28.75%16.86M
-147.41%-10.82M
-100.77%-63.17K
30.05%-1.92M
854.40%23.66M
144.70%22.83M
73.38%8.21M
-1.25%-2.75M
-139.32%-3.14M
Net profit
-152.59%-26.2M
-119.46%-52.92M
-29.77%141.54M
12.28%134.17M
41.89%49.82M
40.18%272.01M
38.83%201.53M
40.67%119.5M
80.07%35.11M
74.86%194.04M
Net profit from continuing operation
-152.59%-26.2M
-119.46%-52.92M
-29.77%141.54M
12.28%134.17M
41.89%49.82M
40.18%272.01M
38.83%201.53M
40.67%119.5M
80.07%35.11M
74.86%194.04M
Less:Minority Profit
----
-471.04%-180.18K
-388.72%-118.51K
-195.03%-39.01K
----
140.02%48.56K
170.14%41.05K
161.07%41.05K
229.26%41.05K
-2.17%-121.35K
Net profit of parent company owners
-152.59%-26.2M
-119.39%-52.74M
-29.69%141.66M
12.35%134.21M
42.06%49.82M
40.07%271.97M
38.74%201.49M
40.51%119.46M
79.56%35.07M
74.78%194.16M
Earning per share
Basic earning per share
-152.17%-0.24
-119.52%-0.49
-29.57%1.31
12.73%1.24
43.75%0.46
39.44%2.51
38.81%1.86
39.24%1.1
77.78%0.32
31.39%1.8
Diluted earning per share
-152.17%-0.24
-119.52%-0.49
-29.57%1.31
12.73%1.24
43.75%0.46
40.22%2.51
38.81%1.86
39.24%1.1
77.78%0.32
30.66%1.79
Other composite income
-2,296.51%-32.35K
94.95%-6.88K
103.55%2.25K
99.17%-507.93
-1.35K
-136.19K
-63.25K
-61.14K
Other composite income of parent company owners
-2,296.51%-32.35K
94.95%-6.88K
103.55%2.25K
99.17%-507.93
---1.35K
---136.19K
---63.25K
---61.14K
----
----
Total composite income
-152.65%-26.23M
-119.47%-52.93M
-29.74%141.54M
12.33%134.17M
41.89%49.82M
40.11%271.88M
38.79%201.47M
40.59%119.44M
80.07%35.11M
74.86%194.04M
Total composite income of parent company owners
-152.65%-26.23M
-119.41%-52.75M
-29.67%141.66M
12.40%134.21M
42.06%49.82M
40.00%271.83M
38.70%201.42M
40.44%119.4M
79.56%35.07M
74.78%194.16M
Total composite income of minority owners
----
-471.04%-180.18K
-388.72%-118.51K
-195.03%-39.01K
----
140.02%48.56K
170.14%41.05K
161.07%41.05K
229.26%41.05K
-2.17%-121.35K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022
Total operating revenue -40.32%128.73M-21.18%801.92M1.07%721.48M23.88%525.06M34.04%215.7M67.51%1.02B69.65%713.81M72.53%423.86M67.97%160.92M62.27%607.41M
Operating revenue -40.32%128.73M-21.18%801.92M1.07%721.48M23.88%525.06M34.04%215.7M67.51%1.02B69.65%713.81M72.53%423.86M67.97%160.92M62.27%607.41M
Other operating revenue ----594.36%771.48K------0------111.11K------0------0
Total operating cost 0.13%164.77M13.35%809.89M21.10%580.69M33.98%384.88M30.67%164.55M64.56%714.53M75.21%479.52M72.65%287.27M56.00%125.93M67.17%434.2M
Operating cost 9.54%75.16M9.79%385.06M20.09%280.15M15.75%164.07M24.29%68.61M76.98%350.74M83.36%233.29M67.66%141.74M74.43%55.2M61.74%198.18M
Operating tax surcharges -5.03%2.31M73.52%9.9M130.57%7.41M312.20%5.03M1,714.38%2.43M128.88%5.7M113.09%3.21M128.00%1.22M-126.58%-150.76K332.87%2.49M
Operating expense 75.89%2.59M55.01%14.96M67.98%11.34M59.94%6.88M-34.67%1.47M23.08%9.65M32.86%6.75M24.66%4.3M39.06%2.25M16.90%7.84M
Administration expense -4.45%26.8M-39.77%77.47M-54.20%45.4M0.77%61.73M-6.95%28.05M26.82%128.63M66.97%99.13M106.77%61.26M116.60%30.14M111.76%101.43M
Financial expense 368.22%3.44M119.83%4.21M107.92%1.33M88.47%-1.51M79.17%-1.28M49.28%-21.21M49.17%-16.83M41.81%-13.06M44.22%-6.16M-4,845.03%-41.81M
-Interest expense (Financial expense) 25.49%4.31M139.85%17.05M173.75%12.11M213.43%7.77M2,063.42%3.43M438.83%7.11M348.79%4.42M172.17%2.48M-80.20%158.75K-64.00%1.32M
-Interest Income (Financial expense) 80.60%-923.67K54.22%-13.04M49.08%-10.91M40.39%-9.36M25.53%-4.76M32.20%-28.48M34.82%-21.43M30.22%-15.71M43.18%-6.39M-1,749.73%-42.01M
Research and development -16.56%54.47M32.06%318.29M52.66%235.05M61.94%148.68M46.22%65.27M45.13%241.02M35.53%153.97M29.89%91.81M1.42%44.64M104.68%166.07M
Credit Impairment Loss 17.78%-1.56M-213.51%-30.91M-284.65%-13.86M-238.74%-10.36M-8.54%-1.9M-38.11%-9.86M-7.14%-3.6M-322.42%-3.06M-49.88%-1.75M-126.61%-7.14M
Asset Impairment Loss 93.55%-172.4K21.82%-10.09M17.64%-6.25M-40.35%-8.76M-72.74%-2.67M-342.41%-12.91M-179.00%-7.59M-521.27%-6.24M-228.85%-1.55M-101.20%-2.92M
Other net revenue 342.97%8.12M-348.15%-26.43M-16.21%-9.95M16.10%-6.24M-27.56%-3.34M-138.23%-5.9M-325.38%-8.56M-872.93%-7.44M-247.44%-2.62M250.07%15.43M
Fair value change income ---------------------------------------2.92M
Invest income 3,354.81%1.08M-5,081.61%-5.59M-6,331.89%-6.59M23.10%130.09K--31.27K89.78%-107.91K110.01%105.68K113.81%105.68K-----62.29%-1.06M
-Including: Investment income associates -----7,008.51%-7.05M---6.91M--72.03K--31.27K113.33%102.05K------------15.63%-765.36K
Asset deal income --0--------------05,050.07%780.71K--958.06K--968.78K------15.16K
Other revenue 634.24%8.78M24.49%20.16M966.69%16.75M1,524.17%12.75M77.16%1.2M-44.99%16.2M-80.48%1.57M-87.68%784.74K-88.87%674.9K204.83%29.44M
Operating profit -158.39%-27.91M-111.58%-34.39M-42.04%130.83M3.71%133.94M47.67%47.81M57.45%297.02M55.62%225.72M60.95%129.16M92.02%32.37M58.54%188.64M
Add:Non operating Income 62.01%151.55K4.18%400.76K-11.63%281.68K-13.88%165.26K306.92%93.54K-84.16%384.7K-96.68%318.74K-98.00%191.9K-36.04%22.99K1,567.96%2.43M
Less:Non operating expense 1,385.72%22.41K19.76%2.07M-76.19%400.26K-99.90%1.56K-95.31%1.51K941.31%1.73M934.56%1.68M1,149.98%1.64M-70.54%32.18K-11.53%165.84K
Total profit -158.01%-27.78M-112.20%-36.06M-41.74%130.72M5.01%134.11M48.00%47.9M54.88%295.68M45.22%224.36M42.39%127.71M92.80%32.36M60.50%190.91M
Less:Income tax cost 17.41%-1.59M-28.75%16.86M-147.41%-10.82M-100.77%-63.17K30.05%-1.92M854.40%23.66M144.70%22.83M73.38%8.21M-1.25%-2.75M-139.32%-3.14M
Net profit -152.59%-26.2M-119.46%-52.92M-29.77%141.54M12.28%134.17M41.89%49.82M40.18%272.01M38.83%201.53M40.67%119.5M80.07%35.11M74.86%194.04M
Net profit from continuing operation -152.59%-26.2M-119.46%-52.92M-29.77%141.54M12.28%134.17M41.89%49.82M40.18%272.01M38.83%201.53M40.67%119.5M80.07%35.11M74.86%194.04M
Less:Minority Profit -----471.04%-180.18K-388.72%-118.51K-195.03%-39.01K----140.02%48.56K170.14%41.05K161.07%41.05K229.26%41.05K-2.17%-121.35K
Net profit of parent company owners -152.59%-26.2M-119.39%-52.74M-29.69%141.66M12.35%134.21M42.06%49.82M40.07%271.97M38.74%201.49M40.51%119.46M79.56%35.07M74.78%194.16M
Earning per share
Basic earning per share -152.17%-0.24-119.52%-0.49-29.57%1.3112.73%1.2443.75%0.4639.44%2.5138.81%1.8639.24%1.177.78%0.3231.39%1.8
Diluted earning per share -152.17%-0.24-119.52%-0.49-29.57%1.3112.73%1.2443.75%0.4640.22%2.5138.81%1.8639.24%1.177.78%0.3230.66%1.79
Other composite income -2,296.51%-32.35K94.95%-6.88K103.55%2.25K99.17%-507.93-1.35K-136.19K-63.25K-61.14K
Other composite income of parent company owners -2,296.51%-32.35K94.95%-6.88K103.55%2.25K99.17%-507.93---1.35K---136.19K---63.25K---61.14K--------
Total composite income -152.65%-26.23M-119.47%-52.93M-29.74%141.54M12.33%134.17M41.89%49.82M40.11%271.88M38.79%201.47M40.59%119.44M80.07%35.11M74.86%194.04M
Total composite income of parent company owners -152.65%-26.23M-119.41%-52.75M-29.67%141.66M12.40%134.21M42.06%49.82M40.00%271.83M38.70%201.42M40.44%119.4M79.56%35.07M74.78%194.16M
Total composite income of minority owners -----471.04%-180.18K-388.72%-118.51K-195.03%-39.01K----140.02%48.56K170.14%41.05K161.07%41.05K229.26%41.05K-2.17%-121.35K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +184.24%
Sample Name
Sample Code
 +20.02%
Sample Name
Sample Code
 +20.00%
4
Henan Shijia Photons Technology
688313
+20.00%
5
Hanjia Design Group
300746
+20.00%
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs

Investment Course

How to Buy Stocks for Beginners
Learn stock market basics and confidently start investing with our beginner-friendly guide to buying stocks. Start your investment journey today!
What Is Options Trading and How to Trade Options
Options trading is carried out by all kinds of investors within individual investment portfolios. Learn how you can put options to work within your own portfolio.
What To Know About Margin Accounts
Discover the essentials of margin accounts, including their benefits, risks, and how to use them effectively in your trading strategy.
Cash Accounts - Covering the Basics
Discover the essentials of cash accounts. Learn what cash accounts are, how they function, their potential benefits, and the differences between cash and margin accounts.
Understanding Fractional Shares: A Beginner's Guide
Discover the basics of fractional shares, how they work, and the process for buying and selling them.

- No more -